Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
5
×
boston top stories
life sciences
national blog main
biotech
boston
national top stories
new york blog main
cancer
clinical trials
drug development
drugs
fda
national
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abbvie
access biotechnology
access industries
akcea therapeutics
alnylam pharmaceuticals
anemia
arvinas
atlas ventures
blood diseases
blood disorders
boulder/denver blog main
boulder/denver top stories
brian macdonald
cancer autoimmune diseases. peloton therapeutics
cedilla therapeutics
codiak biosciences
crispr
crispr therapeutics
crispr-cas9
cutaneous t-cell lymphoma
dana-farber cancer institute
What
cells
5
×
medicine
new
gene
known
oxygen
red
adapt
advance
alnylam
anemia
approves
based
begin
biosciences
bio’s
blood
body
brings
bubbles
cancer
carry
cas
cellular
changes
class
clinical
codiak
crispr
defect
disc
drive
drug
edited
editing
ema
employ
europe
exosome
exosomes
Language
unset
Current search:
cells
×
" boston blog main "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
